Caprion Proteomics With facilities in Montreal, Quebec and Menlo Park, California, Caprion has been providing proteomics biomarker and target identification services since 2002, and has performed over fifty large-scale biomarker discovery and validation projects for over twenty major pharmaceutical industry clients from North America, Europe, and Asia in virtually every major disease indication.